Fen Li: Clinical Trials

2 trials sponsored by Fen Li, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Fen Li: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
Telitacicept, Hydroxychloroquine, Prednisone - Systemic Lupus Erythematosus
Phase 4UnknownFen Li302022-12-312024-01-17
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
methotrexate(necessary), infliximab, etanercept - Rheumatoid Arthritis
Phase 4UnknownFen Li2402016-01-012016-08-25

Conditions studied

Arthritis, Rheumatoid (1)  ·  Lupus Erythematosus, Systemic (1)

Interventions

Prednisone (2)  ·  Adalimumab (1)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Cyclophosphamide (1)  ·  Etanercept (1)  ·  Glucocorticoids (1)  ·  Hydroxychloroquine (1)  ·  Infliximab (1)  ·  Leflunomide (1)  ·  Licensure (1)  ·  Methylprednisolone (1)  ·  Mycophenolic Acid (1)  ·  Tacrolimus (1)  ·  prednylidene (1)  ·  telitacicept (1)

Countries

China (1)